Exercise Prevents Amyloid-β-Induced Hippocampal Network Disruption by Inhibiting GSK3β Activation

Abstract

Exercise is becoming a promising therapeutic approach to prevent alterations both in Alzheimer’s disease (AD) patients and in transgenic models of AD. This neuroprotection has been associated with changes in hippocampal structure and function, as well as with the reduction of amyloid-β (Aβ) production and accumulation. However, whether exercise produces lasting changes in hippocampal population activity and renders it resistant to Aβ-induced network dysfunction is still unknown. Thus, we tested whether voluntary exercise changes hippocampal population activity and prevents its alteration in the presence of Aβ, which has been associated to glycogen synthase kinase-3β (GSK3β) activation. We found that the hippocampal population activity recorded in slices obtained from mice that exercised voluntarily (with free access to a running wheel for 21 days) exhibits higher power and faster frequency composition than slices obtained from sedentary animals. Moreover, the hippocampal network of mice that exercised becomes insensitive to Aβ-induced inhibition of spontaneous population activity. This protective effect correlates with the inability of Aβ to activate GSK3β, is mimicked by GSK3β inhibition with SB126763 (in slices obtained from sedentary mice), and is abolished by the inhibition of PI3K with LY294002 (in slices obtained from mice that exercised). We conclude that voluntary exercise produces a lasting protective state in the hippocampus, maintained in hippocampal slices by a PI3K-dependent mechanism that precludes its functional disruption in the presence of Aβ by avoiding GSK3β activation.

Keywords

Amyloid-β GSK3β hippocampus PI3K spontaneous population activity voluntary-exercise

INTRODUCTION

Amyloid-β (Aβ) plays a major role in cognitive deficits that characterize Alzheimer’s disease (AD) [1 –5], which are mainly mediated by Aβ-induced neural-network dysfunctions [3 , 7]. We have previously shown that Aβ decreases the power of hippocampal-entorhinal cortex population activity both in vivo [8, 9] and in vitro [10] by activating a transduction pathway that involves several protein kinases such as Fyn [5 , 11] and glycogen synthase kinase-3β (GSK3β) [7 –9]. In fact, either the absence or the pharmacological inhibition of any one of these kinases precludes the Aβ-induced reduction in hippocampus-entorhinal cortex population activity [5 , 12]. These findings provide mechanistic support for the protective effect of GSK3β inhibition on the cognitive impairment induced by Aβ application [13], that is observed in transgenic AD models too [14].

Interestingly, there are non-pharmacological approaches that also reduce GSK3β activity [15 –17]. Among these, exercise not only inhibits GSK3β [15, 16] but also improves hippocampal function and cognition in normal humans [18] and AD patients [4 , 20], as well as in naïve [21 –24] and AD-transgenic rodents [25]. Thus, while acknowledging that exercise can reduce Aβ production and accumulation [26], we speculate that the beneficial cognitive effects of exercise in AD [4 , 20] and AD-animal models [27] could involve changes in the hippocampal network function [23] and Aβ-induced GSK3β activation [5, 10], which would protect the hippocampus against Aβ-induced inhibition of neural network activity [9, 28]. Thus, we aimed to test whether or not voluntary exercise modifies hippocampal activity and the activation of GSK3β by Aβ. We found that voluntary exercise changes the hippocampal population activity, which also becomes insensitive to Aβ-induced inhibition. This protective effect correlates with the inability of Aβ to activate GSK3β, possibly involving phosphoinositide-3-kinase (PI3K).

MATERIALS AND METHODS

Animals

All experimental procedures were approved by the Bioethics Committee of the Instituto de Neurobiología, UNAM, and were carried out according the Norma Oficial Mexicana de la Secretaría de Agricultura (SAGARPA NOM-062-ZOO-1999), which complies with the guidelines of the Institutional Animal Care and Use Committee Guidebook (NIH publication 80-23, Bethesda, MD, USA, 1996). Five-week-old male CD1-mice were maintained in a vivarium and divided into two groups: Sedentary-group (SED) animals were housed individually for three weeks in the same cages where they bred. Simultaneously, exercised-group (EX) animals were housed individually in cages with free access to a running wheel [29]. Animals were left undisturbed in these conditions for 21 days before any further experimental procedure.

Slice preparation

To obtain hippocampal slices, both SED and EX animals were anesthetized with an intraperitoneal injection of sodium pentobarbital (63 mg/Kg) and perfused transcardially with a cold, protective-saline solution containing 238 mM sucrose, 3 mM KCl, 2.5 mM MgCl₂, 25 mM NaHCO₃, and 30 mM D-glucose, pH 7.4, and bubbled with carbogen (95% O₂ and 5% CO₂). Then, animals were decapitated; their brains were removed and dissected in ice-cold artificial cerebrospinal fluid (aCSF) containing 119 mM NaCl, 3 mM KCl, 1.5 mM CaCl₂, 1 mM MgCl₂, 25 mM NaHCO₃, and 30 mM D-glucose, pH 7.4, and bubbled with carbogen. One cerebral hemisphere was mounted onto an agar block with a 30° inclination, and horizontal 400-μm-thick slices containing the hippocampus were cut with a vibratome (Vibratome, St. Louis, MO, USA [2]). Slices were allowed to recover in aCSF at room temperature for at least 60 min before any further experimental manipulation.

Spontaneous population activity recordings

After of the recovery period, the hippocampal slices were transferred into a recording chamber continuously perfused in aCSF recirculating at 17-20 ml/min and 29±1°C. An extracellular electrode (0.5-1.0 MOhms) was located, using a stereoscopic microscope and a micromanipulator, on the CA1 region to record its spontaneous population activity (CA1_SPA). The signal was amplified and slightly filtered (highpass, 0.5 Hz; lowpass, 2.5 KHz) with a wide-band AC amplifier (Grass Instruments, Quincy, MA, USA). This raw signal represents the activity of a local network of neurons [8, 30]. Considering that most of its power (Fig. 1) is concentrated in low-frequency components (0-50 Hz), it might be considered a local field potential (normally filtered at < 500 Hz), which is believed to be generated by membrane currents of the neurons in the local neighborhood of the recording electrode [30]. However, considering that the activity is obtained from the CA1 pyramidal cell layer and that we use a 2.5 KHz lowpass filter, the activity also contains the spiking of local neurons [8, 30]. For these reasons, we call this signal CA1_SPA and consider that it represents the alternating expression of different population activity patterns (see [31]). Electrodes were left in position for at least 15 min before commencing recordings. Control experiments were performed to confirm that CA1_SPA remains stable for at least 3 h (Fig. 1; [6]). In all cases basal activity was recorded for 30 min. In some experiments, Aβ 10 nM was added to the bath after basal recordings, and its effects were continuously recorded for 60 min. In another set of experiments, we evaluated the effect of Aβ 10 nM in the presence of either the GSK3β-specific inhibitor SB126763 10 nM [12] or the PI3K inhibitor LY294002 10μM [32], which where bath applied after basal recordings, and its effects were continuously recorded over 60 min. Then, in the continuous presence of either kinase inhibitor, Aβ 10 nM was added to the bath, and its effects were continuously recorded for another 60 min. At the end of all experiments, lidocaine 1 mM was bath applied to verify the viability of the slice [10]. The signals were digitized (at 3 KHz) and stored in a personal computer with an acquisition system from National Instruments (Austin, TX, USA) using custom-made software designed in the LabView environment.

Aβ preparation

Aβ_1 - 42 was obtained from American Peptides. The oligomerization protocol was performed as previously described [10, 33]. Briefly, 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) was added to solid Aβ_1 - 42, at a final peptide concentration of 1 mM, and incubated for 60 min at room temperature. HFIP was allowed to evaporate overnight. Then a 5 mM solution was prepared by adding DMSO. Such solution was then diluted with F12 medium to reach a final concentration of 100μM. This solution was incubated at 5°C for 24 h. Finally, this solution was centrifuged at 14,000 rpm for 10 min in the cold, and the supernatant containing the Aβ oligomers, as well as monomers [10], was collected and used for the experiments.

Western blot

For western blot analysis of the GSK3β phosphorylation-state, we use independent slices that underwent experimental procedures previously described [12, 34], after which their protein content was extracted [12, 34]. Slices were placed in a frozen tube and homogenized in ice-cold lysis buffer, containing: 50 mM Trizma Base, 150 mM NaCl, 1% Triton, 0.5% SDS, 25 mM NaF, 1 mM Na4P2O7, 10 mM Na3VO4, 20 mM β-glycerophosphate, and protease inhibitors [12, 34]. Samples were pre-cleaned by centrifugation at 14,000 rpm and stored at –80°C. For electrophoresis, cell homogenates were boiled for 10 min and centrifuged for 5 min at 10,000 rpm. After adding 2X Laemmli sample buffer, 15μL per lane of the total homogenate was loaded onto a 10% SDS-PAGE gel. After electrophoresis, proteins were transferred onto a polyvinyl difluoride (PVDF) membrane and were incubated for 1 h in a blocking buffer consisting of 20 mM Trizma base, 137 mM NaCl, and 0.05% Tween (TBS-T), pH 7.6 and 7.5% nonfat dry milk. After that, the membranes were incubated with phospho-GSK-3α/β (Ser21/9) rabbit polyclonal antibody (Cell Signaling Technology) diluted in TBS-T buffer at 4°C. The membranes were then washed twice with TBS-T and twice with normal TBS (20 mM Trizma base and 137 mM NaCl, pH 7.6), then incubated with the horseradish peroxidase-conjugated secondary antibody (goat anti-rabbit IgG-HRP Ab; SantaCruz Biotechnology) at a 1:5,000 dilution in TBS-T for 1–2 h. Proteins were visualized using Western Blot Luminol Reagent (Santa Cruz Biotechnology). The membranes then were reanalyzed for total GSK3β using the GSK3β rabbit monoclonal antibody (Cell Signaling Technology). To do so, PVDF membranes were stripped in a buffer solution (containing 0.070 mL 2-mercaptoethanol, 2 mL 10% SDS, 1.26 mL 0.5 M Tris, pH 6.8, and 6.67 mL deionized water) for 30 min at 50°C with occasional agitation. Thereafter, the membranes were washed four times with deionized water, twice with normal TBS, and then processed as described above.

Data analysis

Segments of 40 s of the recording, at the end of each experimental condition, were analyzed by means of a Rapid Fourier Transform, with a Hamming window, using Clampfit (Molecular Devices). The power between 1-50 Hz was integrated for each slice and each condition. We also used the time-frequency analysis available in EEGLAB (http://sccn.ucsd.edu/eeglab.

The integrated power of the activity of SED and EX slices was compared with an unpaired t-test. The integrated power after Aβ application was compared against control activity using a paired t-test. To analyze the difference between the activity of SED and EX slices in control conditions, we first calculated the relative power as the ratio of each frequency power to the total power between 1-50 Hz. To compare the difference of relative power, a Mann-Whitney test was performed for each frequency. We also performed a spectral difference analysis to represent the % change for the power of each frequency in the EX-group spectra with respect to the mean power of the same frequency in the SED-group spectra. To compare the differences between the SED and EX-groups, a Mann-Whitney test was performed for each frequency. Photographs of western blots were scanned, and the optical density (OD) was quantified with ImageJ. To obtain the GSK3β phosphorylation ratio, the OD of p-S9GSK3β was divided by the OD of total GSK3β for all the conditions. To compare the differences of pGSK3β/tGSK3β before and after Aβ application we use a paired t-test. To compare the CA1_SPA the GSK3β phosphorylation ratio after the treatment with SB126763 10 nM or LY294002 10μM and with the corresponding values after the subsequent application of Aβ 10 nM, the activity was normalized to the control conditions (set as 100%). To compare the differences between these groups, a Friedman test with a Dunn’s post hoc test were performed. The statistical analysis was performed with Prism software, and a p value < 0.05 was considered significant.

RESULTS

CA1 spontaneous population activity and GSK3β phosphorylation are stable over time in vitro

As previously reported, CA1 spontaneous population activity (CA1_SPA) in vitro is characterized by low-voltage, non-rhythmic activity that includes a broad range of frequency components whose power is stable for several hours [8, 10] (Fig. 1A). Similarly, in this study we found that CA1_SPA power (quantified as % of control, i.e., basal recording) does not change after continuous recording for 60 min (104.40±5.26% of control), 90 min (100.30±7.16% of control), or 150 min (98.39±19.14% of control) (Fig. 1A) (n = 7). Since we have previously shown that GSK3β is involved in the inhibition of spontaneous population activity induced by Aβ [12], we also tested the stability of GSK3β activity (measured as serine phosphorylation [12]) in our experimental conditions. Indeed, we found that GSK3β phosphorylation does not change after the slices are continuously present in the bath for 60 min (94.74±28.19 % of control), 90 min (114.30±14.27% of control), or 150 min (109.90±8.01% of control) (n = 3).

Exercise changes CA1 spontaneous population activity

Before testing the effects of Aβ on CA1_SPA we tested whether exercise changes this activity (Figs.1 and 2). We found that the CA1_SPA showed higher integrated power (from 1 to 50 Hz) in slices obtained from the EX than from the SED group. The integrated power of the CA1_SPA obtained from the EX slices was 4.12±0.58μV², which is significantly higher (p < 0.05, n = 7) than the power found in slices obtained from the SED group (2.53±1.62μV², n = 7) (Fig. 2B). Exercise not only enhances the power of the CA1_SPA of slices obtained from the EX group, but it also changes its frequency components (Fig. 1). For instance, the CA1_SPA of EX group slices exhibits enhanced power in the frequency band between 16 and 20 Hz, whereas its power is reduced around 4.8 Hz compared with the CA1_SPA of slices obtained from the SED group (Fig. 1B-D, n = 7, Mann-Whitney test).

Exercise protects CA1 spontaneous population activity against Aβ-induced inhibition

After recording the CA1_SPA in control conditions in slices obtained from the EX and SED groups, Aβ was added to the recording chamber, and its effect was evaluated for 60 min. As previously shown [10, 12], Aβ produces a generalized decrease in the power of all frequency components of the CA1_SPA, which reduces the integrated power from 2.53±1.62μV² to 1.50±0.73μV² (a reduction of 50.01±12.27%, Fig. 2B, n = 7, paired t-test). This reduction in the integrated power of the CA1_SPA of slices obtained from the SED group closely correlates with the reduced serine phosphorylation of GSK3β, which is indicative of its activation, passing from 0.37±0.07 O.D. to 0.25±0.07 O.D. (Fig. 2 C, n = 5, paired t-test). In contrast, when Aβ was applied to slices obtained from the EX group, the integrated power of the CA1_SPA remained without change at 4.08±0.61μV² (Fig. 2B, n = 7). This resistance of the CA1_SPA of slices obtained from the EX group to the inhibitory effect of Aβ also correlates with the inability of Aβ to alter the phosphorylation state of GSK3β, which remains unchanged when comparing its levels in control conditions (0.41±0.09 pGSK3β/tGSK3β) to those after 60 min in the continuous presence of Aβ (0.51±0.04 pGSK3β/tGSK3β) (Fig. 2C, n = 5).

The inhibition of CA1 spontaneous population activity induced by Aβ depends on GSK3β activation

As previously demonstrated in the entorhinal cortex [12], the inhibitory effects of Aβ on spontaneous network activity require GSK3β activity. We tested whether this mechanism is also involved in the inhibition of CA1_SPA observed in slices obtained from the SED group as follows: after recording control activity, the specific GSK3β inhibitor SB126763 10 nM was bath applied, and its effect was evaluated for 1 h. Then, Aβ was applied, and its effect was evaluated for 1 h in the continuous presence of SB126763 (Fig. 3). The power of the CA1_SPA of slices obtained from the SED groups remained unchanged after the application of SB126763 10 nM (114.60±14.92% of control). Moreover, the power of CA1_SPA also remained unchanged after Aβ application in the continuous presence of SB126763 (118.88±13.53% of control, n = 7) (Fig. 3). The western blot analysis of slices obtained from the SED group showed that the GSK3β phosphorylation state did not change after the application of SB126763 10 nM (109.80±24.94%, n = 3) or after the subsequent application of Aβ in the continuous presence of SB126763 (105.70±20.90%, n = 3).

The protective effect of exercise on CA1 spontaneous population activity against Aβ-induced inhibition requires PI3K activity

Considering that several of the protective effects of exercise require the activation of PI3K [35, 36], we tested whether this was the case for the protection of CA1 spontaneous population activity against Aβ-induced inhibition. Thus, we tested the effect of the specific PI3K inhibitor LY294002 10μM on the CA1_SPA of slices obtained from the EX group and whether this inhibitor altered the effects of Aβ. After recording the control activity of slices obtained from the EX group, LY294002 10μM was applied and recording was continued for 1 h. Then, Aβ was applied and its effect was evaluated for one hour in the continuous presence of LY294002 (Fig. 4). After the application of LY294002 10μM, the power of CA1_SPA remained unchanged (105.40±14.92% of control), but upon Aβ application in the continuous presence of LY294002, the power of the CA_SPA decreased significantly to 60.37±13.50% of control (Fig. 4, n = 7, Friedman test). The western blot analysis of slices obtained from the EX group and subjected to the same experimental procedure showed that the inhibition of PI3K is not sufficient to change the phosphorylation state of GSK3β (115.70±31.82% of control), but that upon Aβ application, there is a reduction in GSK3β phosphorylation to 73.77±12.27% of control (Fig. 4, n = 4, Friedman test with Dunn’s post hoc test).

DISCUSSION

Our results show that 3 weeks of voluntary exercise induce a persistent modulation of the hippocampal circuit that changes its CA1_SPA (Fig. 1B-C) and makes it resistant to the deleterious effects of Aβ ex vivo by avoiding GSK3β activation and by promoting PI3K activity (Fig. 5). Furthermore, our results show a strong correlation between Aβ-induced CA1_SPA inhibition and GSK3β activation (Fig. 5). Although the source of the reduction in spontaneous population activity induced by Aβ has not been precisely revealed, there is evidence that it is certainly related to a reduction in synaptic transmission [8,10, 8,10] and action potential desynchronization [37].

During exercise, the amplitude and frequency of hippocampal network activity increases [38, 39], along with neuronal firing [38] and synaptic transmission [23 , 41]. However, this study is one of few showing that such functional changes can last longer than the exercise period [23 , 43] and that they can even be observed ex vivo [23 , 44]. It is known that exercise can induce long-lasting effects in several neuroprotective transduction pathways, which could contribute to the sustainably of exercise-induced changes in network function [21, 43] by producing a long-lasting protective state that would render the hippocampal network resistant to Aβ-induced disruptions [21, 40]. Despite the accruing evidence that exercise can have beneficial effects in AD patients and AD-models [40, 45], this is the first demonstration that it might do so by avoiding the deleterious effects of Aβ on network function. Thus, it is likely that exercise not only prevents Aβ production and accumulation [26], but it might prevent the action of Aβ itself on network function by inhibiting protein kinase GSK3β and by promoting PI3K activity.

Abundant evidence indicates that Aβ could activate intracellular signal cascades that ultimately activate GSK3β (for review see [11]). We, and others, have demonstrated that deleterious effects produced by Aβ involve the activation of GSK3β and that these disruptions can be reversed by the pharmacological inhibition of GSK3β with lithium or more specific inhibitors [12–14 , 46]. These results agree with our finding that the specific inhibition of GSK3β with SB126763 prevents the inhibitory effect produced by Aβ on the CA1_SPA of slices obtained from SED animals (Fig. 3), indicating that our original observation, that GSK3β is involved in the Aβ-induced inhibition of spontaneous population activity in the entorhinal cortex, is also true for the CA1 hippocampal subfield. The results also indicate that non-pharmacological manipulations that inhibit GSK3β can be successful against Aβ-induced deleterious effects and possibly against AD.

Interestingly, we also found that the pharmacological inhibition of PI3K eliminates the exercise-induced neuroprotective effect against Aβ-induced CA1_SPA inhibition (Fig. 4). Abundant evidence also indicates that exercise leads to several neurochemical changes that converge in the activation of PI3K [36 , 48] and the subsequent inhibition of GSK3β both in naïve [35, 49] and AD mouse models [16, 48]. In contrast to previous observations [50, 51], which show that PI3K inhibition by itself leads to GSK3β activation [50, 51], we found that the inhibition of PI3K in slices obtained from EX animals was not sufficient to activate GSK3β, but instead, it allows Aβ to activate this kinase and to inhibit CA1_SPA (Fig. 4). We can only speculate that the neuroprotective effect of exercise is so strong that PI3K inhibition no longer results in GSK3β activation and that further stimulation, such as Aβ application, is required to activate GSK3β and to disrupt neural network activity after exercising. One possibility is that exercise changes GSK3β compartmentalization [52 –55], as it does for glycogen-synthase [56], thereby modifying the regulation of GSK3β with respect to different transduction pathways or pathophysiological conditions [52 –55]. In fact, it has been shown that changes in GSK3β compartmentalization interfere with PI3K-mediated cellular events [57].

In summary, we present evidence that voluntary exercise produces a long-lasting neuroprotective change that modifies hippocampal function and makes it resistant to deleterious insults, such as those induced by Aβ through GSK3β activation. The protective effect of exercise involves the reduction in GSK3β recruitment, possibly by the activation PI3K, which provides a mechanistic explanation for a promising, non-pharmacological approach to deal with AD as well as with other pathological conditions that involve disruptions in hippocampal network function.

Footnotes

ACKNOWLEDGMENTS

We thank Dr. Dorothy Pless for editorial comments, Dr. Benito Ordaz for technical assistance, and Dr. Gonzalo Martínez de la Escalera for providing access to his vivarium. Arturo González Isla “forma parte del programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México (UNAM) y recibe actualmente la beca No. 514592 de CONACyT”. This study was supported by CONACyT Grants 117, 235789, 246888 and 181323; and by DGAPA-UNAM Grants IN200715 and IN201415.

Authors’ disclosures available online ().

References

Näslund

, Haroutunian

, Mohs

, Davis

, Davies

, Greengard

, Buxbaum

(2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283, 1571–1577.

Peña

, Gutierrez-Lerma

, Quiroz-Baez

, Arias

(2006) The role of β-amyloid protein in synaptic function: Implications for Alzheimer’s disease therapy. Curr Neuropharmacol 4, 149–163.

Gutiérrez-Lerma

, Ordaz

, Peña-Ortega

(2013) Amyloid beta peptides differentially affect hippocampal theta rhythms in vitro. Int J Pept 2013, 328140.

Wolfsgruber

, Jessen

, Koppara

, Kleineidam

, Schmidtke

, Frölich

, Kurz

, Schulz

, Hampel

, Heuser

, Peters

, Reischies

, Jahn

, Luckhaus

, Hüll

, Gertz

H-J

, Schröder

, Pantel

, Rienhoff

, Rüther

, Henn

, Wiltfang

, Maier

, Kornhuber

, Wagner

(2015) Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI. Neurology 84, 1261–1268.

Salgado-Puga

, Peña-Ortega

(2015) Cellular and network mechanisms underlying memory impairment induced by amyloidβ protein. Protein Pept Lett 22, 303–321.

Palop

, Mucke

(2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer’s disease: From synapses toward neural networks. Nat Neurosci 13, 812–818.

Sun

M-K

, Alkon

(2002) Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid(25-35). J Neurophysiol 87, 2441–2449.

Peña

, Ordaz

, Balleza-Tapia

, Bernal-Pedraza

, Márquez-Ramos

, Carmona-Aparicio

, Giordano

(2010) Beta-amyloid protein (25-35) disrupts hippocampal network activity: Role of Fyn-kinase. Hippocampus 20, 78–96.

Peña-Ortega

, Bernal-Pedraza

(2012) Amyloid beta peptide slows down sensory-induced hippocampal oscillations. Int J Pept 2012, 8.

10.

Balleza-Tapia

, Huanosta-Gutierrez

, Márquez-Ramos

, Arias

, Peña

(2010) Amyloid oligomers decrease hippocampal spontaneous network activity in an age dependent manner. Curr Alzheimer Res 7, 453–462.

11.

Balleza-Tapia

, Peña

(2009) Pharmacology of the intracellular pathways activated by amyloid beta protein. Mini Rev Med Chem 9, 724–740.

12.

Peña-Ortega

, Solis-Cisneros

, Ordaz

, Balleza-Tapia

, Lopez-Guerrero

(2012) Amyloid beta 1-42 inhibits entorhinal cortex activity in the beta-gamma range: Role of GSK-3. Curr Alzheimer Res 9, 857–863.

13.

Álvarez-Ruíz

, Carrillo-Mora

(2013) Amyloid beta 25-35 impairs reconsolidation of object recognition memory in rats and this effect is prevented by lithium carbonate. Neurosci Lett 548, 79–83.

14.

Zhang

, Heng

, Li

, Yang

, Zhang

, Du

, Doody

, Le

(2011) Long-term treatment with lithium alleviates memory deficits and reduces amyloid-β production in an aged Alzheimer’s disease transgenic mouse model. J Alzheimers Dis 24, 739–749.

15.

Bayod

, Menella

, Sanchez-Roige

, Lalanza

, Escorihuela

, Camins

, Pallàs

, Canudas

(2013) Wnt pathway regulation by long-term moderate exercise in rat hippocampus. Brain Res 1600, 111.

16.

Liu

, Zhao

, Zhang

, Shi

(2013) Long-term treadmill exercise inhibits the progression of Alzheimer’s disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Behav Brain Res 256, 261–272.

17.

Jain

, Baitharu

, Prasad

, Ilavazhagan

(2013) Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: Role of BDNF/PI3K/GSK3β pathway coupled with CREB activation. PLoS One 8, e62235.

18.

Griffin

ÉW

, Mullally

, Foley

, Warmington

, O’Mara

, Kelly

(2011) Aerobic exercise improves hippocampal function and increases BDNF in the serum of young adult males. Physiol Behav 104, 934–941.

19.

Ströhle

, Schmidt

, Schultz

, Fricke

, Staden

, Hellweg

, Priller

, Rapp

, Rieckmann

(2015) Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: A systematic review and meta-analysis of effects on cognition in randomized controlled trials. Am J Geriatr Psychiatry 12, 1234–1249.

20.

Groot

, Hooghiemstra

, Raijmakers

PGHM

, van Berckel

BNM

, Scheltens

, Scherder

EJA

, van der Flier

, Ossenkoppele

(2015) The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials. Ageing Res Rev 25, 13–23.

21.

Suijo

, Inoue

, Ohya

, Odagiri

, Takamiya

, Ishibashi

, Itoh

, Fujieda

, Shimomitsu

(2012) Resistance exercise enhances cognitive function in mouse. Int J Sports Med 34, 368–375.

22.

Uysal

, Kiray

, Sisman

, Camsari

, Gencoglu

, Baykara

, Cetinkaya

, Aksu

(2015) Effects of voluntary and involuntary exercise on cognitive functions, and VEGF and BDNF levels in adolescent rats. Biotech Histochem 90, 55–68.

23.

Vivar

, Peterson

, van Praag

(2015) Running rewires the neuronal network of adult-born dentate granule cells. Neuroimage. doi: 10.1016/j.neuroimage.2015.11.031.

24.

Inoue

, Hanaoka

, Nishijima

, Okamoto

, Chang

, Saito

, Soya

(2015) Long-term mild exercise training enhances hippocampus-dependent memory in rats. Int J Sports Med 36, 280–285.

25.

Intlekofer

, Cotman

(2013) Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol Dis 57, 47–55.

26.

Yuede

CMC

, Zimmerman

SSD

, Dong

, Kling

MJMJ

, Bero

, Holtzman

, Timson

, Csernansky

(2009) Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer’s disease. Neurobiol Dis 35, 426–432.

27.

Souza

, Filho

, Goes

ATR

, Del Fabbro

, de Gomes

, Savegnago

, Oliveira

, Jesse

(2013) Neuroprotective effect of physical exercise in a mouse model of Alzheimer’s disease induced by β-amyloid1-40 peptide. Neurotox Res 24, 148–163.

28.

Adaya-Villanueva

, Ordaz

, Balleza-Tapia

, Máxrquez-Ramos

, Peña-Ortega

(2010) Beta-like hippocampal network activity is differentially affected by amyloid beta peptides. Peptides 31, 1761–1766.

29.

Koteja

, Garland

, Sax

, Swallow

, Carter

(1999) Behaviour of house mice artificially selected for high levels of voluntary wheel running. Anim Behav 58, 1307–1318.

30.

Burns

, Xing

, Shapley

(2010) Comparisons of the dynamics of local field potential and multiunit activity signals in macaque visual cortex. J Neurosci 30, 13739–13749.

31.

Avella Gonzalez

, van Aerde

, Mansvelder

, van Pelt

, van Ooyen

(2014) Inter-network interactions: Impact of connections between oscillatory neuronal networks on oscillation frequency and pattern. PLoS One 9, e100899.

32.

Tovar-Y-Romo

, Tapia

(2010) VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK. J Neurochem 115, 1090–1101.

33.

Klein

(2002) Aβ toxicity in Alzheimer’s disease: Globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 41, 345–352.

34.

Várquez-Ramos

, Martínez-Ramírez

, Robles-Martínez

, Garay

, García-Carrancá

, Pérez-Montiel

, Castañeda-García

, Arellano

(2014) Paracrine stimulation of P2X7 receptor by ATP activates a proliferative pathway in ovarian carcinoma cells. J Cell Biochem 115, 1955–1966.

35.

Bruel-Jungerman

, Veyrac

, Dufour

, Horwood

, Laroche

, Davis

(2009) Inhibition of PI3K-Akt signaling blocks exercise-mediated enhancement of adult neurogenesis and synaptic plasticity in the dentate gyrus. PLoS One 4, e7901.

36.

Chen

, Russo-Neustadt

(2005) Exercise activates the phosphatidylinositol 3-kinase pathway. Brain Res Mol Brain Res 135, 181–193.

37.

Kurudenkandy

, Zilberter

, Biverstål

, Presto

, Honcharenko

, Strömberg

, Johansson

, Winblad

, Fisahn

(2014) Amyloid-β-induced action potential desynchronization and degradation of hippocampal gamma oscillations is prevented by interference with peptide conformation change and aggregation. J Neurosci 34, 11416–11425.

38.

Ahmed

, Mehta

(2012) Running speed alters the frequency of hippocampal gamma oscillations. J Neurosci 32, 7373–7383.

39.

Chen

, Resnik

, McFarland

, Sakmann

, Mehta

(2011) Speed controls the amplitude and timing of the hippocampal gamma rhythm. PLoS One 6, e21408.

40.

García-Mesa

, López-Ramos

, Giménez-Llort

, Revilla

, Guerra

, Gruart

, Laferla

, Cristòfol

, Delgado-García

, Sanfeliu

(2011) Physical exercise protects against Alzheimer’s disease in 3xTg-AD mice. J Alzheimers Dis 24, 421–454.

41.

Patten

, Sickmann

, Hryciw

, Kucharsky

, Parton

, Kernick

, Christie

(2013) Long-term exercise is needed to enhance synaptic plasticity in the hippocampus. Learn Mem 20, 642–647.

42.

Crabbe

, Dishman

(2004) Brain electrocortical activity during and after exercise: A quantitative synthesis. Psychophysiology 41, 563–574.

43.

Shen

, Tong

, Balazs

, Cotman

(2001) Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus. Neuroscience 107, 219–229.

44.

Vasuta

, Caunt

, Samadi

, Schibuk

, Kannangara

, Titterness

, Cristie

(2007) Effects of exercise on NMDA receptor subunit contributions to bidirectional synaptic plasticity in the mouse dentate gyrus. Hippocampus 17, 1201–1208.

45.

Winchester

, Dick

, Gillen

, Reed

, Miller

, Tinklenberg

, Mungas

, Chui

, Galasko

, Hewett

, Cotman

(2013) Walking stabilizes cognitive functioning in Alzheimer’s disease (AD) across one year. Arch Gerontol Geriatr 56, 96–103.

46.

Shipton

, Leitz

, Dworzak

, Acton

CEJ

, Tunbridge

, Denk

, Dawson

, Vitek

, Wade-Martins

, Paulsen

, Vargas-Caballero

(2011) Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J Neurosci 31, 1688–1692.

47.

Fang

, Lee

, Seo

, Cho

, Lee

, Park

, Kim

(2013) Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats. Neurosci Res 76, 187–194.

48.

, Kang

, Koo

, Kim

(2011) Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer’s disease. Neurosci Res 69, 161–173.

49.

Bayod

, del Valle

, Canudas

, Lalanza

, Sanchez-Roige

, Camins

, Escorihuela

, Pallas

(2011) Long-term treadmill exercise induces neuroprotective molecular changes in rat brain. J Appl Physiol 111, 1380–1390.

50.

Eickholt

, Walsh

, Doherty

(2002) An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J Cell Biol 157, 211–217.

51.

Zhang

, Lipovsky

, Dibble

, Sahin

, Manning

(2006) S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell 24, 185–197.

52.

Bijur

, Jope

(2003) Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport 14, 2415–2419.

53.

Cohen

, Goedert

(2004) GSK3 inhibitors: Development and therapeutic potential. Nat Rev Drug Discov 3, 479–487.

54.

Bechard

, Dalton

(2009) Subcellular localization of glycogen synthase kinase 3beta controls embryonic stem cell self-renewal. Mol Cell Biol 29, 2092–2104.

55.

Curry

, Torres-Cabala

, Warneke

, Zhang

, Prieto

(2012) Distinct subcellular localization of GSK-3β in melanocytic nevi: Implications in melanocyte senescence. Open J Pathol 2, 113–119.

56.

Prats

, Helge

, Nordby

, Qvortrup

, Ploug

, Dela

, Wojtaszewski

JFP

(2009) Dual regulation of muscle glycogen synthase during exercise by activation and compartmentalization. J Biol Chem 284, 15692–15700.

57.

, Mahmoudi

, Danenberg

, Bejaoui

, de Lau

, Korswagen

, Schutte

, Clevers

(2009) Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade. J Biol Chem 284, 35308–35313.